Heart attacks destroy cardiomyocytes and disrupt the vascular network that supplies oxygen to the heart muscle. Because adult human cardiomyocytes have limited regenerative capacity, researchers have investigated whether cells produced from human pluripotent stem cells could restore damaged tissue or stimulate the heart’s own repair mechanisms. Cardiovascular progenitors are particularly attractive for this purpose because they can develop toward several heart-related lineages, including muscle, vascular and supportive stromal cells. Yet the behavior of transplanted cells after they are delivered into a living heart remains difficult to observe. Conventional molecular analyses often require tissue to be removed and homogenized, erasing the precise locations of cells and the interactions taking place between the graft and the host.

The team addressed this challenge by applying spatial transcriptomics at multiple time points after transplantation into a pig model of myocardial infarction. Spatial transcriptomics combines gene-expression profiling with positional information, allowing researchers to determine not only which genes are active but also where those genes are being expressed within a tissue section. In this study, the approach enabled the investigators to distinguish human xenograft signals from the surrounding porcine myocardium and to examine how both compartments changed as healing progressed. Instead of producing a single molecular snapshot, the time-series design provided a dynamic view of engraftment, revealing how the transplanted progenitors adapted to the hostile, oxygen-poor and fibrotic environment of an infarcted heart.

The analysis showed that the human cardiovascular progenitors gradually increased expression of genes associated with a more mature cardiac state. These included programs involved in oxidative metabolism, the process by which cells generate energy efficiently through mitochondrial respiration. The grafted cells also upregulated genes linked to calcium handling, a central function in cardiac contraction because calcium ions regulate the interaction between contractile proteins inside muscle cells. Such changes suggest that the transplanted progenitors were not remaining in an undifferentiated state. Instead, they appeared to be responding to the cardiac environment and moving toward a phenotype better suited to functioning within heart tissue.

The molecular data also indicated a shift in pathways related to fibrosis. Following myocardial infarction, excessive deposition of extracellular matrix proteins can stiffen the ventricular wall and interfere with electrical conduction and contraction. Although scar formation initially helps prevent the injured heart from rupturing, persistent fibrosis can contribute to long-term heart failure. The observed activation of gene programs associated with fibrosis resolution suggests that the grafted cells may influence the remodeling of the scar environment, either directly or through signals exchanged with host cells. The findings do not establish that the transplanted progenitors alone remove scar tissue, but they provide evidence that their presence is associated with a tissue environment moving toward repair rather than continued damage.

To identify the signals responsible for communication between the human graft and the pig heart, the researchers performed cell–cell communication analysis. This computational strategy examines ligand–receptor relationships: molecules released by one cell type are matched with receptors expressed by another, allowing scientists to predict which cellular conversations may be biologically important. Among the candidate signals, Midkine emerged as a prominent regulator connected to host neovascularization. MDK is a secreted growth factor involved in cell survival, migration and tissue remodeling. In the context of an infarcted heart, its production by the human progenitors suggested a mechanism through which transplanted cells could act at a distance, stimulating neighboring host cells rather than needing to become large numbers of new cardiomyocytes themselves.

The investigators then tested the MDK hypothesis experimentally. Immunohistochemistry was used to examine protein-level patterns in the tissue, providing an independent validation of the transcriptomic findings. They also used lentiviral gene delivery to increase MDK expression in the relevant cells and conducted functional assays to determine whether the factor altered endothelial behavior. Endothelial cells form the inner lining of blood vessels, and their ability to migrate is a key early step in angiogenesis. The experiments demonstrated enhanced endothelial cell migration when MDK activity was increased. In transplanted hearts, MDK overexpression was associated with greater density of CD31-positive vessels, with CD31 serving as a commonly used marker of endothelial cells and vascular structures.

These results place neovascularization at the center of the graft’s therapeutic activity. Restoring blood flow is crucial after infarction because surviving cardiomyocytes at the edge of the injury remain vulnerable to oxygen deprivation. New or remodeled vessels can improve nutrient delivery, remove metabolic waste and create conditions that support tissue stabilization. The findings suggest that human cardiovascular progenitors may function as biological signal generators, releasing factors such as MDK that recruit or activate the host’s own endothelial cells. This paracrine mechanism may be as important as, or potentially more important than, the direct replacement of lost heart muscle. It also creates a possible therapeutic strategy in which MDK or related pathways are targeted to promote vascular repair.

The study’s use of a pig model is significant because porcine hearts resemble human hearts in size, anatomy and aspects of cardiac physiology more closely than many small-animal systems. At the same time, the work remains preclinical. A higher density of CD31-positive structures indicates increased vascularization, but future studies will need to determine whether those vessels are fully functional, carry effective blood flow and improve measurable cardiac performance over the long term. Researchers will also need to assess the durability, safety and electrical behavior of the grafted cells, as well as the potential consequences of altering MDK activity in other organs. The immune response to human cells in a large-animal setting and the reproducibility of the treatment will be important considerations before clinical translation.

To make the extensive dataset accessible, the researchers have created a publicly available interactive Shiny atlas containing spatial and temporal transcriptomic information from pig hearts affected by myocardial infarction and treated with human xenografts. Interactive resources of this kind allow investigators to explore gene-expression patterns across tissue regions and recovery stages without relying solely on static figures. The atlas may help other groups compare candidate pathways, examine host–graft interactions and generate new hypotheses about cardiac repair. Together, the study and its accompanying resource offer a detailed molecular timeline of transplanted cardiovascular progenitors in an injured heart, while identifying MDK as a tractable target for therapeutic angiogenesis. The work shifts attention from asking only whether stem-cell grafts survive to understanding how they communicate with damaged tissue and recruit the body’s own repair machinery.

Subject of Research: Human pluripotent stem-cell-derived cardiovascular progenitors transplanted into infarcted pig hearts, with a focus on host–graft communication and MDK-mediated neovascularization.

Article Title: Spatiotemporal transcriptomics of human cardiovascular progenitors in pig hearts identifies Midkine as a positive regulator of neovascularization.

Article References: Adusumalli, S., Leong, K.S., Lim, S. et al. “Spatiotemporal transcriptomics of human cardiovascular progenitors in pig hearts identifies Midkine as a positive regulator of neovascularization.” Nature Cardiovascular Research 5, 744–762 (2026). https://doi.org/10.1038/s44161-026-00851-1

Image Credits: AI Generated

DOI: August 2026

Keywords: stem cell therapy, cardiac repair, myocardial infarction, spatial transcriptomics, cardiovascular progenitors, Midkine, MDK, neovascularization, angiogenesis, endothelial cells, pig model, regenerative medicine

Over evolutionary time scales, the human heart gradually lost much of its regenerative prowess, resulting in a system that compensates for injury by forming fibrotic scar tissue rather than regenerating functional muscle cells. This fibrosis, while critical for structural stability following myocardial infarction, can ironically undermine cardiac function as excessive scar tissue compromises contractile capacity. This maladaptive fibrotic remodeling often sets the stage for heart failure and sudden cardiac death. The advent of lifestyle-induced cardiovascular risks—such as poor nutrition, obesity, and sedentary habits—has only further exacerbated the prevalence of heart attacks, emphasizing the urgent need for therapies that can promote true cardiac repair rather than mere scar formation.

In a transformative leap forward, researchers at the University of Würzburg and the University Medical Center Freiburg have employed cutting-edge single-cell RNA sequencing combined with spatial transcriptomics to create a molecular atlas of the heart after injury. This atlas resolves the heart’s cellular architecture down to individual mRNA molecules, revealing a dynamic and highly coordinated interplay between diverse cell populations during the tissue repair process. By mapping the spatial distribution and temporal evolution of these cells, the team has unveiled critical signaling pathways and cellular interactions that underpin cardiac healing.

At the core of this healing nexus are macrophages—specialized immune cells traditionally known for their role in inflammation and clearance of cellular debris. The research uncovered that specific subsets of macrophages act as regulators of connective tissue cells, modulating their activity to prevent excessive fibrotic scar expansion. This regulatory crosstalk is spatially precise and temporally orchestrated, highlighting macrophages not just as cleanup agents but as pivotal architects of the tissue microenvironment. These findings propose that fine-tuning macrophage behavior could significantly curtail deleterious fibrosis and support the preservation of myocardial contractility.

Professor Dominic Grün, renowned for his expertise in computational biology and spatial biomedical systems, emphasized that their atlas provides a foundational framework for future research aimed at targeting the molecular dialogue between cardiac cell types. “Understanding the cellular choreography post-injury allows us to conceptualize targeted interventions that could mitigate maladaptive scarring,” he stated. This study marks a paradigm shift away from broad-spectrum therapies towards precision medicine approaches tailored to the heart’s unique cellular milieu.

Dr. Andy Chan, the study’s lead author, remarked on the translational implications, noting that the detailed elucidation of cardioimmune signaling pathways opens new therapeutic avenues. For instance, modulating macrophage-mediated signaling could be leveraged to reprogram the post-infarction microenvironment, fostering regenerative rather than fibrotic outcomes. This insight represents a critical stepping stone toward developing biologics or small molecules that harness the heart’s intrinsic repair mechanisms.

The Collaborative Research Center 1425, which spearheaded this investigation, is dedicated to innovative diagnostics and treatments for heart disease. Professor Peter Kohl, a leading figure in cardiac physiology and the center’s spokesperson, highlighted how integrating molecular insights with clinical strategies could revolutionize patient outcomes. “Our collective aim is to leverage the heart’s endogenous healing capabilities to generate healthier scar tissue, thereby preserving cardiac function,” Kohl explained. Such an integrative research model, combining computational tools, molecular biology, and clinical expertise, exemplifies the future of cardiovascular medicine.

Further contributions from Dr. Franziska Schneider-Warme underscored the vital role of interdisciplinary collaboration. Her experience at the University Medical Center Freiburg enriched the study with clinical perspectives, ensuring that the molecular findings were contextualized within real-world therapeutic challenges. Together, the team’s diverse expertise enabled comprehensive analysis from bench to bedside.

This study was recently published in the prestigious journal Nature Cardiovascular Research, underscoring its high impact and relevance. The article titled “Spatiotemporal dynamics of the cardioimmune niche during lesion repair” details the extensive datasets and computational models underpinning the spatial mapping of heart tissue post-infarction. Such peer-reviewed validation attests to the robustness and novelty of the findings, which are poised to influence a broad spectrum of cardiovascular research and treatment strategies.

Beyond its immediate scientific contributions, this work captures the crucial importance of understanding spatial and temporal cellular dynamics in complex tissues. The heart’s repair process, guided by a delicate balance of immune activity and tissue remodeling, exemplifies cellular systems biology at its finest. By integrating high-resolution transcriptomic data with sophisticated spatial techniques, the research sets a new standard for studying tissue regeneration and pathology.

Looking ahead, the challenge remains to translate these cellular and molecular insights into viable clinical interventions. Pharmaceutical development targeting specific macrophage states or signaling pathways identified in the atlas represents a promising frontier. Moreover, advancing imaging and sequencing technologies will further refine our comprehension of cardiac repair mechanisms. This holistic approach may ultimately culminate in therapies that can restore cardiac function and improve quality of life for millions of heart attack survivors globally.

In summary, this pioneering study not only illuminates the cellular dance that governs heart healing but also charts a course for future therapeutic innovation. The creation of a spatially resolved cellular atlas has revealed the indispensable roles of immune cells in coordinating tissue repair and offers a framework for mitigating pathological scarring. As cardiovascular disease remains a leading cause of morbidity worldwide, such advances provide critical hope for transforming outcomes through precision medicine and regenerative biology.

Subject of Research: Cellular and molecular mechanisms underlying heart repair and scar formation after cardiac infarction

Article Title: Spatiotemporal dynamics of the cardioimmune niche during lesion repair

News Publication Date: 3-Nov-2025

Web References: http://dx.doi.org/10.1038/s44161-025-00739-6

Image Credits: Andy Chan / Würzburg University

Keywords: cardiac regeneration, heart repair, myocardial infarction, fibrosis, macrophages, single-cell RNA sequencing, spatial transcriptomics, cardioimmune niche, tissue remodeling, heart failure, Collaborative Research Center 1425

Cardiac regeneration has been a major focus in regenerative medicine because the adult mammalian heart notoriously exhibits limited regenerative capacity after injury, such as myocardial infarction. Traditional views have mostly centered on the intrinsic capacity of cardiomyocytes or stem cell-based strategies. However, this research distinctly highlights the nuanced role of the border zone—the area surrounding the infarct—where cardiomyocytes remain viable but are subjected to microenvironmental stressors and immune cell infiltration. The interplay in this niche appears to orchestrate a molecular and cellular symphony, whereby cardiomyocytes and immune cells collaboratively remodel the ECM, facilitating effective tissue regeneration.

The extracellular matrix is far more than just a scaffold; it is a dynamic and highly regulated milieu that governs cell behavior, mechanical properties, and biochemical signaling. During cardiac injury, the ECM undergoes drastic changes, which if unbalanced, lead to fibrosis and adverse remodeling, impeding heart function. What Constanty et al. reveal is that macrophages infiltrating the border zone do not merely act as inflammatory responders but actively mediate ECM composition by secreting matrix metalloproteinases and cytokines that fine-tune the local environment. This remodeling, in turn, promotes the extension of cellular protrusions from border-zone cardiomyocytes, a phenomenon indicative of heightened cellular motility and possibly dedifferentiation or re-entry into the cell cycle.

Through the utilization of cutting-edge imaging techniques and molecular profiling, the study meticulously documents how cardiomyocyte protrusions physically interact with the remodeled ECM matrix. These protrusions appear to be essential mediators enabling cells to migrate and communicate over short distances, suggesting a coordinated effort in repopulating the damaged heart tissue. Supplementing these insights, transcriptomic analyses highlight the upregulation of integrins and cytoskeletal regulators in border-zone cardiomyocytes, which are known to be critical for protrusive activity and mechanotransduction.

One of the more fascinating aspects uncovered is the bidirectional signaling between macrophages and cardiomyocytes. Macrophages in the border zone shift toward a reparative phenotype, characterized by anti-inflammatory and pro-regenerative secretomes, which significantly influence the behavior of the cardiomyocytes. Conversely, cardiomyocytes emit signals that modulate macrophage function, fostering an environment conducive to healing rather than chronic inflammation. This dynamic feedback loop underscores the complexity and sophistication of innate immune interactions in tissue repair beyond their conventional roles.

The implications of these findings extend beyond basic biology; they offer a blueprint for therapeutic strategies aimed at harnessing or replicating this natural regenerative capacity. By targeting the signaling pathways and molecular mediators involved in ECM remodeling and cell protrusion, novel biomaterials or small molecule drugs could be designed to enhance cardiac repair post-infarction. For instance, modulating macrophage polarization or augmenting cardiomyocyte protrusion-promoting factors might mitigate scar formation and restore functional myocardium more effectively.

Moreover, this study challenges the existing dogma that cardiomyocytes in mammals are terminally differentiated and incapable of meaningful proliferation post-injury. The data suggest that, at least in the border zone, cardiomyocytes retain a latent plasticity, manifested through their ability to extend protrusions and potentially migrate or divide. This opens a compelling narrative that the microenvironmental context, particularly the ECM and immune cell landscape, significantly governs cardiomyocyte regenerative potential.

The detailed mechanistic insights gathered were made possible by innovative experimental models, including lineage tracing, in vivo imaging, and multiplexed immunostaining, which allowed the authors to visualize dynamic cellular behaviors in real-time within an intact myocardial setting. These technological advances are rapidly transforming regenerative research by enabling the dissection of complex spatiotemporal cellular interactions that were previously inaccessible.

Furthermore, the study touches on the critical balance between ECM degradation and synthesis during regeneration. Excessive degradation leads to structural instability, while insufficient remodeling precipitates fibrosis. The precise temporal and spatial control achieved by macrophages ensures the ECM remains malleable without compromising tissue integrity, enabling cell protrusions to navigate and anchor appropriately. This balanced remodeling is likely regulated by a tightly coordinated network of proteases, inhibitors, and growth factors.

Notably, the authors also discuss potential evolutionary underpinnings of this regenerative mechanism. Certain lower vertebrates capable of robust heart regeneration possess similar cardiomyocyte-immune cell-ECM interactions, suggesting a conserved biological program that mammals have attenuated. Understanding how to reactivate or enhance these pathways in humans could revolutionize treatments for heart failure.

In addition to therapeutic considerations, this research provides a new framework to reevaluate past experimental data on cardiac repair. It suggests that interventional studies aiming solely at boosting cardiomyocyte proliferation without addressing ECM remodeling or immune cell dynamics might be insufficient or suboptimal. An integrative approach that considers the multifaceted microenvironmental factors is thus paramount.

The multidisciplinary nature of the research team, comprising experts in cardiology, immunology, molecular biology, and bioengineering, reflects the complexity of cardiac regeneration as a field. This convergence of disciplines was instrumental in unraveling how cellular behavior is dictated by diverse but interconnected pathways, offering a more holistic understanding of myocardial repair processes.

Looking forward, the findings prompt several exciting research questions: How can the macrophage-cardiomyocyte dialogue be precisely manipulated in vivo? Are there unique molecular markers that distinguish regenerative macrophages that could be targeted? What are the long-term outcomes of enhanced cardiomyocyte protrusion in terms of electrical coupling and contractile function? Addressing these will be crucial for translating these discoveries into clinical reality.

In conclusion, Constanty et al.’s work marks a transformative step in decoding the cellular choreography that enables cardiac regeneration. Their elucidation of how border-zone cardiomyocytes and macrophages synergistically remodel the ECM to facilitate cardiomyocyte protrusion not only enhances fundamental biological understanding but also ignites new hope for regenerative therapies in ischemic heart disease. As heart failure continues to be a leading cause of mortality worldwide, such innovative insights pave the way toward reparative strategies that could restore heart function and substantially improve patient outcomes.

Subject of Research: Cellular mechanisms of cardiac regeneration focusing on interactions between border-zone cardiomyocytes, macrophages, and extracellular matrix remodeling.

Article Title: Border-zone cardiomyocytes and macrophages regulate extracellular matrix remodeling to promote cardiomyocyte protrusion during cardiac regeneration.

Article References:
Constanty, F., Wu, B., Wei, KH. et al. Border-zone cardiomyocytes and macrophages regulate extracellular matrix remodeling to promote cardiomyocyte protrusion during cardiac regeneration. Nat Commun 16, 3823 (2025). https://doi.org/10.1038/s41467-025-59169-4

Image Credits: AI Generated